PulmCCM - Jun 12, 2016 - By JE
"The results of the ATACH II trial are out; we have even more guidance when managing the blood pressure of hypertensive patients with supratentorial, intra-cerebral hemorrhage of less than 60 cm3 in volume. The question: should such patients have their systolic blood pressure lowered to 110-139 mmHg within 4.5 hours or can we target 140-179 mmHg? There was relatively strict adherence to the use of intravenous nicardipene as the anti-hypertensive of choice in this trial...
In ATACH II, there was no difference in death or disability, there was no difference in hematoma volume and at one week, those patients randomized to the intensive group were 5% more likely to suffer kidney injury."